MedPath

Recommending Zinc Sulfate supplement as a new treatment approach in obese children to improve metabolic profiles (such as LDL, HDL, blood sugar) in plasma

Phase 1
Conditions
Metabolic Syndrome.
Other disorders of lipoprotein metabolism
Registration Number
IRCT138808061434N2
Lead Sponsor
Vice Chancellery for Research, Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

underwriting consent form by one of parents or legal guardian, simple obesity, pre-pubertal stage, no underlying health disorder
Exclusion criteria: Possible drug side effects, no compliance for follow up

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath